Medical Data Vision Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	6,539	5,906	6,419	6,104	5,672
Revenue Growth (YoY)	10.72%	-7.99%	5.16%	7.62%	23.87%
Cost of Revenue	1,986	1,576	1,388	1,075	1,029
Gross Profit	4,553	4,330	5,031	5,029	4,643
Selling, General & Admin	4,203	4,025	3,162	2,938	2,732
Research & Development	-	290	68	332	316
Operating Expenses	4,201	4,327	3,260	3,271	3,049
Operating Income	352	3	1,771	1,758	1,594
Interest & Investment Income	3	-	-	-	-
Earnings From Equity Investments	-5	-514	-72	-	-
Other Non Operating Income (Expenses)	10	1	1	-8	-3
EBT Excluding Unusual Items	360	-510	1,700	1,750	1,591
Gain (Loss) on Sale of Investments	-290	-127	-15	51	-
Asset Writedown	-4	-4	-116	-375	-
Other Unusual Items	-	-86	-1	-	-1
Pretax Income	66	-727	1,568	1,426	1,590
Income Tax Expense	-210	76	613	569	491
Earnings From Continuing Operations	276	-803	955	857	1,099
Minority Interest in Earnings	4	12	24	13	-12
Net Income	280	-791	979	870	1,087
Net Income to Common	280	-791	979	870	1,087
Net Income Growth	-	-	12.53%	-19.96%	55.29%
Shares Outstanding (Basic)	38	38	38	38	39
Shares Outstanding (Diluted)	38	38	38	38	39
Shares Change (YoY)	-0.79%	-0.10%	-0.10%	-2.44%	-0.81%
EPS (Basic)	7.40	-20.73	25.63	22.75	27.74
EPS (Diluted)	7.40	-20.73	25.63	22.75	27.74
EPS Growth	-	-	12.64%	-17.97%	56.55%
Free Cash Flow	720	-1,031	1,586	857	1,058
Free Cash Flow Per Share	19.02	-27.02	41.52	22.41	27.00
Dividend Per Share	-	6.500	6.500	6.000	5.600
Dividend Growth	-	-	8.33%	7.14%	55.56%
Gross Margin	69.63%	73.31%	78.38%	82.39%	81.86%
Operating Margin	5.38%	0.05%	27.59%	28.80%	28.10%
Profit Margin	4.28%	-13.39%	15.25%	14.25%	19.16%
Free Cash Flow Margin	11.01%	-17.46%	24.71%	14.04%	18.65%
EBITDA	460	130	1,872	1,907	1,729
EBITDA Margin	7.03%	2.20%	29.16%	31.24%	30.48%
D&A For EBITDA	108	127	101	149	135
EBIT	352	3	1,771	1,758	1,594
EBIT Margin	5.38%	0.05%	27.59%	28.80%	28.10%
Effective Tax Rate	-	-	39.09%	39.90%	30.88%
Advertising Expenses	-	508	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.